VEGFA and cancer: Isoflurane is associated with increased gene expression of vascular endothelial growth factor (VEGF), angiopoietin-1, and interleukin-8; and decreased T helper type 1 to T helper type 2 (Th1/Th2) ratio, suggesting disruption of cancer immunosurveillance [6, 9, 10].